Metagenomi, Inc. (MGX) is a cutting-edge biotechnology firm dedicated to pioneering gene editing therapies using a unique metagenomics-derived genome editing toolbox. Based in Emeryville, California, the company is positioned at the forefront of genetic medicine, focusing on developing transformative therapeutics to address significant unmet medical needs across diverse indications. Metagenomi is committed to advancing precision medicine and aims to reshape the treatment landscape through its proprietary technologies and strategic collaborations, reflecting its vision to lead innovation in the biopharmaceutical industry.
Click "Analyze" to generate stock analysis
MGX Price Trend and Signals
MGX Financials
2025-10-22Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-16Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.